Research map: Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trial

Back to the article

Papers in this map

  1. Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition · Hélène Salmon · 2016 · 1214 citations · Cited by this paper
  2. TGF-β1 drives neutrophil extracellular traps formation to promote CD8 + T cell exhaustion via the ERK-c-Fos-JunB axis, mediating gastric cancer immunotherapy resistance · 2026 · Related
  3. Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma · Edward W. Roberts · 2016 · 1065 citations · Cited by this paper
  4. Pharmacologic activity, safety, and preliminary efficacy of GEN3009, a CD37-targeting DuoHexaBody, in relapsed or refractory B-cell non-Hodgkin’s lymphoma · 2026 · Related
  5. Differentiation of Phagocytic Monocytes into Lymph Node Dendritic Cells In Vivo · Gwendalyn J. Randolph · 1999 · 901 citations · Cited by this paper
  6. Safety and efficacy of fecal microbiota transplantation in solid cancers resistant to immune checkpoint inhibitors: results of the MITRIC trial · 2026 · Related
  7. Dendritic cell migration in inflammation and immunity · Juan Liu · 2021 · 544 citations · Cited by this paper
  8. Circumventing Ewing sarcoma tumor microenvironment resistance by IL1RAP CAR-modified TGFβ1-imprinted natural killer cells in combination with IL-15 agonist and anti-GD2 antibody · 2026 · Related
  9. Mechanisms and Consequences of Dendritic Cell Migration · David Álvarez · 2008 · 538 citations · Cited by this paper
  10. HDAC inhibitors reverse YAP-driven immune resistance in NSCLC: mechanistic and translational evidence · 2026 · Related
  11. Combination of p53 Cancer Vaccine with Chemotherapy in Patients with Extensive Stage Small Cell Lung Cancer · Scott Joseph Antonia · 2006 · 448 citations · Cited by this paper
  12. Efficient discovery of an agonistic anti-OX40 nanobody by epitope-directed approach to address enrichment-driven epitope bias · 2026 · Related
  13. Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy · Maud Mayoux · 2020 · 395 citations · Cited by this paper
  14. Systemic immune profiling in hepatocellular carcinoma: navigating etiological heterogeneity and selection bias · 2026 · Related
  15. INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect · Alberto Chiappori · 2010 · 126 citations · Cited by this paper
  16. In situ generation of proinflammatory CAR macrophages via mRNA-TLR agonist co-delivery for triple-negative breast cancer immunotherapy · 2026 · Related
  17. Durable complete response to neoantigen-loaded dendritic-cell vaccine following anti-PD-1 therapy in metastatic gastric cancer · Zengqing Guo · 2022 · 86 citations · Cited by this paper
  18. Guarding epithelial integrity: origins of adaptive immunity and cancer immunosurveillance over time and space · 2026 · Related
  19. Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study · Martin Reck · 2024 · 81 citations · Cited by this paper
  20. UDP-glucuronate decarboxylase 1 promotes tumor immune evasion by accelerating KMT2D loss in hepatocellular carcinoma · 2026 · Related
  21. Combination immunotherapy of glioblastoma with dendritic cell cancer vaccines, anti-PD-1 and poly I:C · Ping Zhu · 2023 · 58 citations · Cited by this paper
  22. A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study · Marta Español‐Rego · 2022 · 34 citations · Cited by this paper
  23. XCR1+ DCs are critical for T cell-mediated immunotherapy of chronic viral infections · Eva Domenjo‐Vila · 2023 · 28 citations · Cited by this paper
  24. The Spatial Organization of cDC1 with CD8+ T Cells is Critical for the Response to Immune Checkpoint Inhibitors in Patients with Melanoma · Élisa Gobbini · 2025 · 27 citations · Cited by this paper
  25. The Real-World Outcome of First Line Atezolizumab in Extensive-Stage Small Cell Lung Cancer: A Multicenter Prospective Cohort Study · Myeong Geun Choi · 2023 · 13 citations · Cited by this paper
  26. Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis · Laura S. Bonanno · 2024 · 12 citations · Cited by this paper
  27. Flt3L-mediated tumor cDC1 expansion enhances immunotherapy by priming stem-like CD8+ T cells in lymph nodes · Junyun Lai · 2026 · 9 citations · Cited by this paper
  28. Transient decrease in human peripheral blood myeloid dendritic cells following influenza vaccination correlates with induction of serum antibody · James J. Kobie · 2014 · 3 citations · Cited by this paper
  29. pDCs amplify tissue-resident memory CD8+ T cell responses during viral reinfection · Elena Hernández-García · 2025 · 2 citations · Cited by this paper
  30. Untitled · Cited by this paper
  31. Untitled · Cited by this paper
  32. Untitled · Cited by this paper
  33. Untitled · Cited by this paper
  34. Untitled · Cited by this paper

Source: OpenAlex (CC0)